Investment Summary

HBM Partners AG, Irving Place Capital, Alta Partners and Polaris Partners Invest In eGenesis

On March 2, 2021, private equity firm HBM Partners AG, private equity firm Irving Place Capital, venture capital firm Alta Partners and growth capital firm Polaris Partners invested in life science company eGenesis

Investment Highlights
  • This is HBM Partners AG’s 50th, Irving Place Capital’s 1st, Alta Partners’ 50th and Polaris Partners’ 22nd transaction in the Life Science sector.
  • This is HBM Partners AG’s 38th, Irving Place Capital’s 40th, Alta Partners’ 50th and Polaris Partners’ 61st transaction in the United States.
  • This is HBM Partners AG’s 9th, Irving Place Capital’s 3rd, Alta Partners’ 8th and Polaris Partners’ 18th transaction in Massachusetts.

Investment Summary

Date 2021-03-02
Target eGenesis
Sector Life Science
Investor(s) HBM Partners AG
Irving Place Capital
Alta Partners
Polaris Partners
Deal Type Venture

Target

eGenesis

Cambridge, Massachusetts, United States
eGenesis is a biotechnology company using breakthrough gene-editing technologies for the development of safe and effective human-compatible organs, tissues, and cells. eGenesis was founded in 2015 and is based in Cambridge, Massachusetts.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 4

Investor

HBM Partners AG

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2001
PE ASSETS 3.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

HBM Partners is a private investment firm focused on investing in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. HBM looks to invest $5 to $50 million per transaction and will consider private and public companies. HBM Partners was established in 2001 and is headquartered in Zug, Switzerland.


DEAL STATS #
Overall 57 of 66
Sector (Life Science) 50 of 57
Type (Venture) 45 of 53
State (Massachusetts) 9 of 13
Country (United States) 38 of 44
Year (2021) 9 of 15
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-01 Parabilis Medicines

Cambridge, Massachusetts, United States

Parabilis Medicines is a biopharmaceutical company with a mission to drastically reduce the burden of disease on patients and their families by inventing new types of drugs that squelch abnormal physiological processes in ways previously imagined but considered unattainable. The company is pioneering the discovery, development and commercialization of Helicon™ peptides, a new drug modality that uniquely combines the cell-permeability and oral dosing optionality of traditional small molecule drugs with the high specificity, broad target accessibility and rapid discovery arc of monoclonal antibody drugs. Parabilis Medicines was founded in 2016 and is based in Cambridge, Massachusetts.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-03 Pyxis Oncology

Boston, Massachusetts, United States

Pyxis Oncology specializes in developing a differentiated portfolio of biologics, including antibody-drug conjugates (ADCs) and immunotherapies, to improve the lives of patients with difficult-to-treat cancers. Pyxis Oncology was founded in 2019 and is based in Boston, Massachusetts.

Buy -
Investor

Irving Place Capital

New York, New York, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1997
PE ASSETS 4.4B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Irving Place Capital (formerly Bear Stearns Merchant Banking) is an independent private equity firm focused on making investments in middle-market companies located in North America and Western Europe. Irving primarily looks for opportunities in the retail, financial services, consumer products and packaging sectors, but will also consider investments in other traditional and service based businesses such as restaurants, transportation/logistics, healthcare, energy, and industrial products/services. The Firm's target investment size is $50 to $250 million of equity capital and EBITDA in excess of $7 million. Prospective transaction situations include traditional management buyouts, growth capital financings, divestitures, consolidations, and recapitalizations. Irving Place is based in New York City.


DEAL STATS #
Overall 49 of 49
Sector (Life Science) 1 of 1
Type (Venture) 2 of 2
State (Massachusetts) 3 of 3
Country (United States) 40 of 40
Year (2021) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-04-09 OTC Industrial Technologies

Columbus, Ohio, United States

OTC Industrial Technologies is an industrial equipment service provider and distributor of highly engineered products including motion control, pumps, finishing products, robotics, motors and air compressors. OTC serves over 13,000 customers across diverse end-markets, providing highly technical sales consultation and aftermarket repair and services. OTC Industrial Technologies was founded in 1963 and is based in Columbus, Ohio.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-14 MRP

Plattsburgh, New York, United States

MRP designs and manufactures rigid plastic packaging components used by millions of consumers in a diverse set of end-markets, with a primary focus on the health and wellness verticals. The Company has a library of 900+ tools used to support a product offering of 10,000+ SKUs and the ability to create a meaningfully higher count of variations. MRP is based in Plattsburgh, New York.

Sell -
Investor

Alta Partners

Jackson, Wyoming, United States

Investor Investor Investor Investor


Category Venture Capital Firm
Founded 1996
PE ASSETS 2.6B USD
Size Large
Type Sector Focused
DESCRIPTION

Alta Partners is a venture capital firm that targets investments in early and later stage life science companies, including biopharmaceuticals, medical technology, and information technology businesses. Alta was formed as an early stage investor but has since expanded its investment range to provide later stage growth capital to private and young public companies. Alta was established in 1996 and is headquartered in San Francisco, California.


DEAL STATS #
Overall 59 of 59
Sector (Life Science) 50 of 50
Type (Venture) 48 of 48
State (Massachusetts) 8 of 8
Country (United States) 50 of 50
Year (2021) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-04 Bioventus

Durham, North Carolina, United States

Bioventus provides clinical and cost-effective therapies and diagnostics to help patients regain active lifestyles. The company's innovative products include bone stimulation devices and osteoarthritis joint fluid therapies. Bioventus was incorporated in 2011 and is based in Durham, North Carolina.

Sell -
Investor

Polaris Partners

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1996
PE ASSETS 5.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Polaris Partners is primarily a seed, first round, and early stage venture capital investor in information technology and life science businesses. However, Polaris also focuses on private equity investments in established companies. In this area, Polaris targets high growth middle market companies in industries including technology, healthcare, digital media, consumer products and services, and business services. The firm's investments include minority growth equity investments, recapitalizations with liquidity, and leveraged buyouts. Polaris Partners was formed in 1996 and has offices in Seattle, Washington and Waltham, Massachusetts.


DEAL STATS #
Overall 66 of 87
Sector (Life Science) 22 of 39
Type (Venture) 38 of 57
State (Massachusetts) 18 of 27
Country (United States) 61 of 78
Year (2021) 2 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-02 Drizly

Boston, Massachusetts, United States

Drizly is a technology company powering shopping experience for beer, wine, and liquor. Drizly was founded in 2012 and is based in Boston, Massachusetts.

Sell $1.1B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-13 Cohere

Boston, Massachusetts, United States

Cohere is creating software aiming at breaking down unintentional silos that have made patient care journeys unnecessarily complex, costly, burdensome, and dissatisfying. Cohere was founded in 2019 and is based in Boston, Massachusetts.

Buy -